DOI: 10.1055/s-00000142

Frauenheilkunde up2date

LinksSchließen

Referenz

Carr B, Dmowski WP, OʼBrien C. et al.
Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density.

Reprod Sci 2014;
21: 1341-1351

Bibliographische Angaben herunterladen

Aufrufen in: